Intraocular melanoma is a rare form of cancer that develops in the eye's melanocytes, the cells responsible for producing melanin. Although uncommon, it is the most common primary intraocular malignancy in adults. Research into intraocular melanoma focuses on understanding its genetic basis, risk factors, and treatment options. Advances in molecular biology have identified genetic mutations associated with the disease, aiding in personalized treatment strategies. Current research efforts also explore novel therapies, including targeted drugs and immunotherapy, to improve outcomes for patients. Early detection through regular eye exams remains crucial for effective management, highlighting the importance of ongoing research in combating this challenging disease.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States